Appendix 4C - Quarterly - 30 June 2025
Filed with ASX · · 7 pages · English
Summary by 6ix AI
The report highlights a successful capital raise and ongoing assessments of new assets to diversify shareholder risk. The company is also pursuing partnerships for its deoxymab assets and has undergone a restructuring of its Board and management.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Patrys
- Entitlement Offer Prospectus
- Non-Renounceable Entitlement Offer
- Deed of Release entered into with CEO
- Successful Placement and Board Changes
- Reinstatement to Official Quotation
Later from Patrys
- Appendix 4E - Preliminary Final Report
- Notice of Annual General Meeting/Proxy Form
- Patrys Receives R&D Tax Incentive Refund
- Appendix 4C - Quarterly - 30 September 2025
- Trading Halt
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys